Dissociation between steroid receptor expression and cell proliferation in the human breast

Cancer Research

Volumn 57, Issue 22, 1997, Pages 4987-4991

  Clarke, Robert B ^a,b   Howell, Anthony ^a   Potten, Christopher S ^b   Anderson, Elizabeth ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

BIOLOGICAL MARKERS; BREAST; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; NEOPLASM PROTEINS; RECEPTORS, ESTRADIOL; RECEPTORS, PROGESTERONE;

EID: 0030670385     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Laidlaw, I. J., Clarke, R. B., Howell, A., Owen, A. W. M. C, Potten, C. S., and Anderson, E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology, 136: 164-171, 1995.
2. Clarke, R. B., Howell, A., and Anderson, E. Estrogen sensitivity of normal human breast tissue in vivo and implanted into nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res. Treat., 45: 121-133, 1997.
3. Green, S. Steroid receptors and new (anti-)steroidal agents: modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. J. Steroid Biochem. Mol. Biol., 37: 747-751, 1990.
4. Potten, C. S., Watson, R. J., Williams, G. T., Tickle, S., Roberts, S. A., Harris, M., and Howell, A. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer, 58: 163-170, 1988.
5. Gerdes, J., Lemke, H., Baisch, H., Wacker, H-H., Schwab, U., and Stein, H. Cell cycle analysis of a proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J. Immunol., 133: 1710-1715, 1984.
6. Masters, J. W. R., Drife, J. O., and Scarisbrick, J. J. Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst., 58: 1263-1265, 1977.
7. Meyer, J. S. Cell proliferation in normal breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine: effects of menstrual phase, age, and oral contraceptive hormones. Hum. Pathol., 8: 67-81, 1977.
8. King, R. J. B. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol., 39: 811-818, 1991.
9. Pike, M. C., Urskin, G., and Spicer, D. V. Experiments on proliferation of normal human breast tissue in nude mice do not show that progesterone does not stimulate breast cells. Endocrinology, 137: 1505-1506, 1996.
10. McGuire, W. L., and Clark, G. M. The prognostic role of progesterone receptors in human breast cancer. Semin. Oncol., 10: 2-6, 1983.
11. Sunderland, M. C., and McGuire, W. L. Hormones and breast cancer. Trends Endocrinol. Metab., 2: 72-76, 1991.
12. Petersen, O. W., Hoyer, P. E., and van Deurs, B. Frequency and distribution of estrogen receptor-positive cells in normal nonlactating human breast tissue. Cancer Res., 47: 5748-5751, 1987.
13. Jacquemier, J. D., Hassoun, J., Torrente, M., and Martin, P-M. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages - immunohistochemical study of 107 cases. Breast Cancer Res. Treat., 15: 109-117, 1990.
14. Williams, G., Anderson, E., Howell, A., Watson, R., Coyne, J., Roberts, S. A., and Potten, C. S. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int. J. Cancer, 48: 206-210, 1991.
15. Dickson, R. B., Huff, K. K., Spencer E. M., and Lippman, M. E. Induction of epidermal growth factor-related polypeptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology, 118: 138-142, 1986.
16. Dickson, R. B., McManaway, M. E., and Lippman, M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science (Washington DC), 212: 1540-1543, 1986.
17. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasin, A., Derynck, R., and Dickson, R. B. Evidence that TGF-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
18. Silberstein, G. B., and Daniel, C. W. Reversible inhibition of mammary gland growth by TGF-β. Science (Washington DC), 237: 291-293, 1987.
19. Snedeker, S. M., Brown, C. F., and DiAugustine, R. P. Expression and functional properties of transforming growth factor-α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. USA, 88: 276-280, 1991.
20. El-Ashry, D., Chrysogelos, S. A., Lippman, M. E., and Kern, F. G. Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes. J. Steroid Biochem. Mol. Biol., 59: 261-269, 1996.
21. Potten, C. S., and Morris, R. J. Epithelial stem cells in vivo. J. Cell Sci., 10 (Suppl.): 45-62, 1988.